Clinical implications of non-breast cancer related findings on FDG-PET/CT scan prior to neoadjuvant chemotherapy in patients with breast cancer.

Josefien P van Olmen A Marjolein Schrijver Marcel P M Stokkel Claudette E Loo Jetske L B Gunster Marie-Jeanne T F D Vrancken Peeters Frederieke H van Duijnhoven Iris M C van der Ploeg

Published in: Breast cancer research and treatment (2024)

FDG-PET/CT scans used for dissemination imaging in BC patients detect a high number of non-BC related additional findings, often clinically irrelevant and causing a large amount of unnecessary work-up. However, in 8% of the patients undergoing diagnostic work-up for an additional finding, a second primary malignancy was detected, warranting diagnostic attention in selected patients.

Keyphrases

neoadjuvant chemotherapy
end stage renal disease
patients undergoing
ejection fraction
newly diagnosed
computed tomography
magnetic resonance imaging
squamous cell carcinoma
high resolution
lymph node
patient reported outcomes
working memory
early stage
sentinel lymph node
mass spectrometry